+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Tocotrienol Market Size, Share & Trends Analysis Report By Product (Alpha, Beta, Gamma, and Delta), By End Use (Dietary Supplement, Pharmaceuticals, Cosmetics, and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5943304
The Latin America, Middle East and Africa Tocotrienol Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030).

Tocotrienols are valued ingredients in skincare and beauty products due to their antioxidant properties and potential benefits for skin health. They support hydration, elasticity, and general skin health by shielding the skin from oxidative damage, UV rays, and outside pollutants. Cosmetic companies are leveraging tocotrienols in formulations for moisturizers, anti-aging creams, serums, sunscreens, and other skincare products, targeting consumers seeking natural and effective solutions for skincare concerns.

Consumers are increasingly seeking tocotrienol products derived from natural and sustainable sources. Manufacturers are responding by prioritizing sustainable palm oil production methods, exploring alternative plant-based sources such as rice bran and annatto seeds, and implementing transparent supply chain practices to meet consumer demands for ethical sourcing. Personalized nutrition is gaining traction as consumers seek tailored solutions to meet their health needs and preferences. Tocotrienol supplements formulated for specific health concerns, such as cardiovascular health, cognitive function, or skincare, are emerging to address the diverse needs of consumers seeking personalized wellness solutions.

The expansion of the pharmaceutical industry in Saudi Arabia can drive formulation and product innovation in tocotrienol-based pharmaceuticals and dietary supplements. With the growth of the pharmaceutical industry, Saudi Arabia may strengthen its healthcare infrastructure, distribution networks, and regulatory framework to facilitate market access for tocotrienol-containing products. In conclusion, the growth of the pharmaceutical sector and the prevailing food and beverage industry in the region are driving the market growth.

The Brazil market dominated the LAMEA Tocotrienol Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $12,769.1 Thousands by 2030. The Argentina market is showcasing a CAGR of 8.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.5% during (2023 - 2030).

Based on Product, the market is segmented into Alpha, Beta, Gamma, and Delta. Based on End Use, the market is segmented into Dietary Supplement, Pharmaceuticals, Cosmetics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Parchem Fine and Specialty Chemicals, Inc.
  • BASF SE
  • Eisai Co., Ltd.
  • Cayman Chemical Company, Inc.
  • Excelvite SDN. BHD.
  • BTSA BIOTECNOLOGÍAS APLICADAS S.L.
  • American River Nutrition, LLC
  • Vance Group Ltd.
  • Kuala Lumpur Kepong Berhad (Davos Life Science)
  • SourceOne Global Partners

Market Report Segmentation

By Product
  • Alpha
  • Beta
  • Gamma
  • Delta
By End Use
  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Others
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Tocotrienol Market, by Product
1.4.2 LAMEA Tocotrienol Market, by End Use
1.4.3 LAMEA Tocotrienol Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Tocotrienol Market, by Product
4.1 LAMEA Alpha Market, by Country
4.2 LAMEA Beta Market, by Country
4.3 LAMEA Gamma Market, by Country
4.4 LAMEA Delta Market, by Country
Chapter 5. LAMEA Tocotrienol Market, by End-use
5.1 LAMEA Dietary Supplements Market, by Country
5.2 LAMEA Pharmaceuticals Market, by Country
5.3 LAMEA Cosmetics Market, by Country
5.4 LAMEA Others Market, by Country
Chapter 6. LAMEA Tocotrienol Market, by Country
6.1 Brazil Tocotrienol Market
6.1.1 Brazil Tocotrienol Market, by Product
6.1.2 Brazil Tocotrienol Market, by End-use
6.2 Argentina Tocotrienol Market
6.2.1 Argentina Tocotrienol Market, by Product
6.2.2 Argentina Tocotrienol Market, by End-use
6.3 UAE Tocotrienol Market
6.3.1 UAE Tocotrienol Market, by Product
6.3.2 UAE Tocotrienol Market, by End-use
6.4 Saudi Arabia Tocotrienol Market
6.4.1 Saudi Arabia Tocotrienol Market, by Product
6.4.2 Saudi Arabia Tocotrienol Market, by End-use
6.5 South Africa Tocotrienol Market
6.5.1 South Africa Tocotrienol Market, by Product
6.5.2 South Africa Tocotrienol Market, by End-use
6.6 Nigeria Tocotrienol Market
6.6.1 Nigeria Tocotrienol Market, by Product
6.6.2 Nigeria Tocotrienol Market, by End-use
6.7 Rest of LAMEA Tocotrienol Market
6.7.1 Rest of LAMEA Tocotrienol Market, by Product
6.7.2 Rest of LAMEA Tocotrienol Market, by End-use
Chapter 7. Company Profiles
7.1 Parchem Fine and Specialty Chemicals, Inc.
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.2 BASF SE
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Eisai Co., Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Cayman Chemical Company, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Acquisition and Mergers:
7.4.3 SWOT Analysis
7.5 Excelvite SDN. BHD.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 BTSA BIOTECNOLOGÍAS APLICADAS S.L.
7.6.1 Company Overview
7.7 American River Nutrition, LLC
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Vance Group Ltd.
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Kuala Lumpur Kepong Berhad (Davos Life Science)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.9.6 SWOT Analysis
7.10. SourceOne Global Partners
7.10.1 Company Overview
7.10.2 SWOT Analysis

Companies Mentioned

  • Parchem Fine and Specialty Chemicals, Inc.
  • BASF SE
  • Eisai Co., Ltd.
  • Cayman Chemical Company, Inc.
  • Excelvite SDN. BHD.
  • BTSA BIOTECNOLOGÍAS APLICADAS S.L.
  • American River Nutrition, LLC
  • Vance Group Ltd.
  • Kuala Lumpur Kepong Berhad (Davos Life Science)
  • SourceOne Global Partners

Methodology

Loading
LOADING...